News

Panion Animal Health listed on AktieTorget

Panion Animal Health AB (publ) ("Panion") has received approval for admission to trading of its shares on AktieTorget. The listing of Panion on AktieTorget facilitates distribution of CombiGene's shares in Panion to CombiGene's shareholders. The first day of trading in Panion's share on AktieTorget is Thursday, 6 July 2017.

The share's ISIN code is SE0008963151 and it will be traded under the symbol PANION. A Company Description issued in conjunction with the listing will be presented on 3 July. The Company Description will be published on Panion's website: www.panion-animalhealth.com

Panion aims to develop and commercialize gene therapy treatments in veterinary medicine based on applications with human health products. Panion's primary focus is on developing a method for effective and safe treatment of canine epilepsy.

"We wish to improve the quality of life for animals with chronic diseases and we are convinced that gene therapy is a treatment form of the future," says Panion's CEO, Anja Holm.

3 JULI 2017

For further information, please contact:
Anja E. H. Holm, VD | + 45-22 94 66 00
anja.holm@panion-animalhealth.com

In June 2015 CombiGene formed a wholly owned subsidiary, then called CombiGene Vet AB, and in April 2016 the decision was taken to distribute the subsidiary to CombiGene's shareholders with the aim of listing the company. The company, which has been renamed Panion Animal Health AB, will use CombiGene's discoveries to develop a treatment for canine epilepsy. Panion aims at inlicensing or acquiring other veterinary medicine projects or products.

panion-animalhealth.com

2017-08-21

Period April-June

  • Net sales: kSEK 0 (0)
  • Operating profit: kSEK -1 269 (0)
  • Earnings per share: SEK -0,10 (-).
  • Liquidity at the end of the period: kSEK 796 (582).

Period January-June

  • Net sales: kSEK 0 (0). 
  • Operating profit: kSEK -2 536 (-). 
  • Earnings per share: SEK -0,21 (-). 
  • Liquidity at the end of the period: kSEK 796 (582).
2017-08-14

Panion has made an agreement with Copenhagen University about transfer and use of technical data from a study in dogs. 

2017-07-14

After raising new capital, veterinary medicine company Panion Animal Health AB is now ready to ramp
up development of its treatment method for canine epilepsy. At the same time, discussions are under
way for a licensing deal that could give Panion access to a new major market.

2017-07-03

Panion Animal Health AB (publ) ("Panion") has received approval for admission to trading of its shares on AktieTorget. The listing of Panion on AktieTorget facilitates distribution of CombiGene's shares in Panion to CombiGene's shareholders. The first day of trading in Panion's share on AktieTorget is Thursday, 6 July 2017.

1
2
3
4
5

Subscribe

Press releases and reports via E-mail.